Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression
- 1 November 2015
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 75 (21) , 4483-4493
Abstract
The chemokine CCL22 is abundantly expressed in many types of cancer and is instrumental for intratumoral recruitment of regulatory T cells (Treg), an important subset of immunosuppressive and tumor-promoting lymphocytes. In this study, we offer evidence for a generalized strategy to blunt Treg activity that can limit immune escape and promote tumor rejection. Activation of innate immunity with Toll-like receptor (TLR) or RIG-I–like receptor (RLR) ligands prevented accumulation of Treg in tumors by blocking their immigration. Mechanistic investigations indicated that Treg blockade was a consequence of reduced intratumoral CCL22 levels caused by type I IFN. Notably, stable expression of CCL22 abrogated the antitumor effects of treatment with RLR or TLR ligands. Taken together, our findings argue that type I IFN blocks the Treg-attracting chemokine CCL22 and thus helps limit the recruitment of Treg to tumors, a finding with implications for cancer immunotherapy. Cancer Res; 75(21); 4483–93. ©2015 AACR.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T CellsScience Translational Medicine, 2013
- Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer ProgressionCancer Research, 2012
- Trial WatchOncoImmunology, 2012
- Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor CellsCancer Research, 2011
- NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor MicroenvironmentThe Journal of Immunology, 2009
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsJournal of Experimental Medicine, 2008
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during MaturationCancer Research, 2008
- TLR7 and TLR8 as targets in cancer therapyOncogene, 2008
- CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cellsJournal of Experimental Medicine, 2007
- Regulating the immune response to tumoursAdvanced Drug Delivery Reviews, 2006